Devices

David Levy, MD, FRCP Patients in the Intensive Care Unit Hyperglycemia, whether associated with known diabetes or not, carries a poor prognosis in critically ill patients through multiple mechanisms, including vascular disease, polyneuropathy, an increased tendency to infection, dyslipidemia, and abnormal anti-inflammatory and coagulation responses. Consistent near-normoglycemia has therefore been a …

  Dexcom is creating an app for the soon-to-be-released Apple Watch to receive and display data from its glucose monitors using their Share technology. The smartwatch, which is due out in April, will display readings as an easy-to-read graph. Dexcom has already created apps for iOS devices including the Follow …

  The FDA has approved Dexcom’s G4 PLATINUM Continuous Glucose Monitoring System with Share. The Dexcom Share receiver uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient’s receiver and an app on the patient’s smartphone to transmit glucose information to apps on the mobile devices of …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP There is a steep age-related increase in the prevalence of diabetes and impaired glucose tolerance which applies equally to both sexes. Overall, diabetes prevalence is higher in men, but there are more women with diabetes. In devel­oping countries, most people with diabetes …

An ultra-thin, flexible sensor that sticks to the skin like a temporary tattoo can detect a person’s blood glucose levels… “The sensor represents the first example of an easy-to-wear flexible tattoo-based epidermal diagnostic device combining reverse iontophoretic extraction of interstitial glucose and an enzyme-based amperometric biosensor,” the researchers wrote. In …

The FDA has approved the Maestro Rechargeable System for treatment of obesity… The Maestro Rechargeable System is indicated for treatment of patients aged at least 18 years with a BMI of 35 to 45 with at least one obesity-related condition and who have failed to lose weight on a weight …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP The vast majority of cases of diabetes in children are type 1, caused by autoimmune destruction of beta cells in the pancre­atic islets. A steady increase in the incidence of type 1 dia­betes has been reported worldwide (average increase 2.5-3% per year …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Pregestational diabetes is the most common medical problem that complicates pregnancy, affecting 1 in 264 births (0.38%) in the UK in 2002–3, with over 25% occurring in women with type 2 diabetes. The Kaiser Permanente database recorded an average rate of 1.3% …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Exercise Regular physical exercise is an important component of the management and prevention of type 2 diabetes (Figure 26.1). Aerobic exercise, in particular, and resistance exercise improve insulin sensitivity and glycemic control. Blood glucose and lipid profiles improve, as well as insulin …

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Particular groups of patients with diabetes are at risk of different psychological problems (Table 25.1). Many chil­dren show remarkable resilience to the diagnosis of diabetes, but about one-third have some temporary psychological distress, mostly ‘adjustment disorders’ such as difficulty in sleeping, depression, …